Moreover, KL-6 concentrations reflecting the extent of damage and regeneration of type II pneumocytes can predict the risk of illness or death in subjects suffering from lung diseases associated with rheumatologic disorders [11]. This evidence concerns the gene MUC1 and lung disorder.